SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001708599-24-000026
Filing Date
2024-11-12
Accepted
2024-11-12 16:03:18
Documents
78
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ser-20240930.htm   iXBRL 10-Q 1150204
2 EX-10.2 serinaq3ex102xemploymentag.htm EX-10.2 68686
3 EX-10.3 serinaq3ex103xflgconsultin.htm EX-10.3 62366
4 EX-31 ser-20240930xexx31.htm EX-31 18976
5 EX-32 ser-20240930xexx32.htm EX-32 5397
11 GRAPHIC image_0a.jpg GRAPHIC 99
12 GRAPHIC image_2.jpg GRAPHIC 143
  Complete submission text file 0001708599-24-000026.txt   7721298

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ser-20240930.xsd EX-101.SCH 52246
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ser-20240930_cal.xml EX-101.CAL 74217
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ser-20240930_def.xml EX-101.DEF 266544
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ser-20240930_lab.xml EX-101.LAB 694732
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ser-20240930_pre.xml EX-101.PRE 504329
81 EXTRACTED XBRL INSTANCE DOCUMENT ser-20240930_htm.xml XML 1045201
Mailing Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806
Business Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806 (256) 327-9630
Serina Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: AL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38519 | Film No.: 241447861
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)